print small

Participating Countries:

Australia

Austria

Belgium

Bulgaria

Canada

Cyprus

Czech Republic

Denmark

European Commission

France

Germany

Greece

Hungary

Ireland

Israel

Italy

Norway

Poland

Portugal

Romania

Russian Federation

Serbia

Slovakia

Slovenia

Spain

Sweden

Switzerland

Turkey

Ukraine

United Kingdom

United States of America

COST is supported by the EU Framework Programme Horizon 2020
This website is supported by COST
6/17/2015 (Added to site)
Author(s): Antonio Aires, Sandra M. Ocampo, David Cabrera, Leonor de la Cueva, Gorka Salas, Francisco J. Teran and Aitziber L. Cortajarena

BSA-coated magnetic nanoparticles for improved therapeutic properties

Journal: Journal Of Materials Chemistry B
DOI: 10.1039/c5tb00833f
Request reprint

In recent years, magnetic nanoparticles have been widely investigated due to their potential in biomedical applications. For successful in vivo applications, magnetic nanoparticles must satisfy several requirements such as biocompatibility, invisibility to the immune system, high colloidal stability in biological fluids, and long blood circulation times. In this study, we have developed a formulation in which the magnetic nanoparticles are coated with bovine serum albumin to provide enhanced colloidal stability in biological fluids preserving their magnetic properties. In addition, the nanoparticles carry a chemotherapeutic drug, showing their potential as drug delivery systems. Our results reveal the influence of protein adsorption on the colloidal stability and the dynamical magnetic response of functionalized magnetic nanoparticles. Moreover, cellular internalization and in vitro cytotoxic activity in Panc-1 pancreatic cancer cells reveal enhanced cellular internalization, successful intracellular drug delivery, and efficient anticancer activity


Keywords: AC field    iron oxide    nanoparticles    protein   

Founding Members

Project Office

STSM



Subscribe to newsletter

Subscribe